Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,906 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon.
McCammon K, Jacoby K, Kalota S, Snyder J, Cline K, Robertson K, Rardin C, Kahan R, Green L, Zuckerman J, Rovner E. McCammon K, et al. Among authors: green l. Neurourol Urodyn. 2018 Jan;37(1):440-448. doi: 10.1002/nau.23324. Epub 2017 Nov 2. Neurourol Urodyn. 2018. PMID: 29095516 Clinical Trial.
Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon.
Winkler H, Jacoby K, Kalota S, Snyder J, Cline K, Robertson K, Kahan R, Green L, McCammon K, Rovner E, Rardin C. Winkler H, et al. Among authors: green l. Female Pelvic Med Reconstr Surg. 2018 May/Jun;24(3):222-231. doi: 10.1097/SPV.0000000000000488. Female Pelvic Med Reconstr Surg. 2018. PMID: 28953076 Free PMC article. Clinical Trial.
Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settings.
Kennelly M, Green L, Alvandi N, Wehbe S, Smith JJ 3rd, MacDiarmid S, Mangel J, Schwartz M, Aboushwareb T, Murray B. Kennelly M, et al. Among authors: green l. Curr Med Res Opin. 2018 Oct;34(10):1771-1776. doi: 10.1080/03007995.2018.1443061. Epub 2018 Mar 20. Curr Med Res Opin. 2018. PMID: 29458265
2,906 results